Methicillin-resistant Staphylococcus aureus (MRSA)
Showing 1 - 25 of 6,004
MRSA Bloodstream Infection, MRSA Bacteremia, MRSA Right-sided Endocarditis Trial in Butte, Toledo (Exebacase)
No longer available
- MRSA Bloodstream Infection
- +3 more
-
Butte, Montana
- +1 more
Aug 25, 2022
Initial and Chronic Methicillin Resistant Staphylococcus Aureus
Completed
- Methicillin-Resistant Staphylococcus Aureus
- Cystic Fibrosis
- Intervention N/A. Observational study
-
Birmingham, Alabama
- +2 more
Jan 19, 2022
Methicillin-resistant Staphylococcus Aureus Infection Trial in Falls Church, Leesburg (Preoperative MRSA screening)
Terminated
- Methicillin-resistant Staphylococcus Aureus Infection
- Preoperative MRSA screening
-
Falls Church, Virginia
- +1 more
Jun 3, 2021
CA-MRSA Transmission: An ED Population Sampling Strategy
Recruiting
- Methicillin-Resistant Staphylococcus Aureus
- Acute Abscess Group
-
Gainesville, FloridaUF Health
Jun 4, 2021
Emergencies Trial (GeneXpert®)
Withdrawn
- Emergencies
- GeneXpert®
- (no location specified)
Nov 9, 2020
Methicillin-Resistant Staphylococcus Aureus Trial (intervention)
Completed
- Methicillin-Resistant Staphylococcus Aureus
- intervention
- (no location specified)
Mar 26, 2020
Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections Trial in Worldwide
Recruiting
- Methicillin-Resistant Staphylococcus Aureus
- +2 more
- Dalbavancin single dose
- +2 more
-
Mobile, Alabama
- +26 more
Jan 27, 2023
Staphylococcus Aureus Bacteremia, Staphylococcus Aureus Septicemia, Staphylococcal Sepsis Trial in Montreal (Ertapenem, Placebo)
Not yet recruiting
- Staphylococcus Aureus Bacteremia
- +3 more
- Ertapenem
- Placebo
-
Montreal, Quebec, CanadaMcGill University Health Centre (Royal Victoria Hospital and Mon
Feb 21, 2022
MRSA Trial in New York (Retapamulin, Placebo Ointment)
Completed
- MRSA
- Retapamulin
- Placebo Ointment
-
New York, New YorkNew York University School of Medicine
Mar 9, 2020
Methicillin-resistant Staphylococcus Aureus Trial in United States (Standard-of-Care Education, MRSA Decolonization)
Completed
- Methicillin-resistant Staphylococcus Aureus
- Standard-of-Care Education
- MRSA Decolonization
-
Aliso Viejo, California
- +23 more
Sep 27, 2021
Methicillin-resistant Staphylococcus Aureus Trial in Saint John (Rifampin, Doxycycline, 2% mupirocin ointment)
Completed
- Methicillin-resistant Staphylococcus Aureus
- Rifampin
- +3 more
-
Saint John, New Brunswick, CanadaSaint John Regional Hospital
Feb 12, 2020
Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus Trial in Paris (Cloxacillin, Cefazolin)
Recruiting
- Bacteremia Due to Methicillin Susceptible Staphylococcus Aureus
-
Paris, FranceFrançois-Xavier Lescure
Dec 7, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
Staphylococcus Aureus Trial in Philadelphia (Bacillus subtilis probiotic, Placebo)
Unknown status
- Staphylococcus Aureus
- Bacillus subtilis probiotic
- Placebo
-
Philadelphia, PennsylvaniaRothman Institute
Feb 18, 2020
Antistaphylococcal Betalactam and Emergence of Resistance
Completed
- Bacterial Resistance
- Methicillin-Sensitive Staphylococcus Aureus Infection
-
Nancy, Lorraine, FranceLefevre
Jul 1, 2023
Infection Control Trial in Baltimore (Enhanced cleaning of surfaces in ICU rooms, Sham enhanced cleaning of surfaces in ICU
Completed
- Infection Control
- Enhanced cleaning of surfaces in ICU rooms
- Sham enhanced cleaning of surfaces in ICU rooms
-
Baltimore, MarylandUniversity of Maryland, Baltimore
Feb 15, 2022
Cystic Fibrosis, Methicillin-resistant Staphylococcus Aureus Trial in Cleveland (Vancomycin)
Withdrawn
- Cystic Fibrosis
- Methicillin-resistant Staphylococcus Aureus
-
Cleveland, OhioRainbow Babies and Children's Hospital, Univeristy Hospitals Cas
Dec 23, 2021
Staphylococcus Aureus, Carbapenem Resistant Gram Negative Bacteria Trial (Targeted gown and gloves use)
Not yet recruiting
- Staphylococcus Aureus
- Carbapenem Resistant Gram Negative Bacteria
- Targeted gown and gloves use
- (no location specified)
Oct 26, 2021
Bacteremia Due to Staphylococcus Aureus, Left Sided Infective Endocarditis (Disorder), Right Sided Infective Endocarditis
Withdrawn
- Bacteremia Due to Staphylococcus Aureus
- +3 more
- Tonabacase (LSVT-1701)
-
Butte, MontanaLsvt-1701-2001
Jun 27, 2022
Cystic Fibrosis Trial in Cincinnati (Ceftaroline)
Active, not recruiting
- Cystic Fibrosis
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Aug 29, 2022
Testing Spread and Implementation of Novel Methicillin Resistant
Completed
- Blood Stream Infections
- MRSA Infections
- healthcare staff processes for infection prevention
-
Portland, MaineMaine Medical Center
Nov 8, 2021
Vancomycin Monitoring
Enrolling by invitation
- MRSA
- Retrospective chart review
-
Dallas, TexasMethodist Dallas Medical Center
May 24, 2022
MRSA, Cystic Fibrosis Trial in Canada, United States (Vancomycin inhalation powder, Placebo inhalation powder)
Completed
- MRSA
- Cystic Fibrosis
- Vancomycin inhalation powder
- Placebo inhalation powder
-
Mobile, Alabama
- +70 more
Nov 4, 2021
Gram-negative Bacilli and MRSA Screening in ICU in China
Unknown status
- Infections, Bacterial
- None intervention. This is an observational study.
-
Hangzhou, Zhejiang, ChinaSir Run Run Shaw Hospital
Mar 18, 2020
Neisseria Gonorrhoeae Infection, Asymptomatic Pharyngeal Carriage Trial (Absence of antibiotic treatment, Ceftriaxone)
Not yet recruiting
- Neisseria Gonorrhoeae Infection
- Asymptomatic Pharyngeal Carriage
- Absence of antibiotic treatment
- Ceftriaxone
- (no location specified)
Jul 24, 2023